The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease

  1. Cuesta, A.M.
  2. Albiñana, V.
  3. Gallardo-Vara, E.
  4. Recio-Poveda, L.
  5. de Rojas-P, I.
  6. de Las Heras, K.V.G.
  7. Aguirre, D.T.
  8. Botella, L.M.
Aldizkaria:
Scientific Reports

ISSN: 2045-2322

Argitalpen urtea: 2019

Alea: 9

Zenbakia: 1

Mota: Artikulua

DOI: 10.1038/S41598-019-46448-6 GOOGLE SCHOLAR lock_openSarbide irekia editor